42 filings
8-K
CLDI
Calidi Biotherapeutics Inc - Ordinary Shares
19 Apr 24
Regulation FD Disclosure
5:25pm
8-K
CLDI
Calidi Biotherapeutics Inc - Ordinary Shares
19 Apr 24
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
5:20pm
8-K
CLDI
Calidi Biotherapeutics Inc - Ordinary Shares
18 Apr 24
Entry into a Material Definitive Agreement
5:00pm
8-K
CLDI
Calidi Biotherapeutics Inc - Ordinary Shares
1 Apr 24
Entry into a Material Definitive Agreement
9:00am
8-K
CLDI
Calidi Biotherapeutics Inc - Ordinary Shares
18 Mar 24
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
8:41am
8-K
lij8ct7bzfyj2phloez
12 Mar 24
Entry into a Material Definitive Agreement
4:51pm
8-K
97nlf1 lkwn
1 Mar 24
Amendments to Articles of Incorporation or Bylaws
5:24pm
8-K
l1zj2km7 iqumzelrt66
28 Feb 24
Regulation FD Disclosure
4:42pm
8-K
9zn50jpn80p
12 Feb 24
Unregistered Sales of Equity Securities
6:30am
8-K
xxze8k 956xpoo
7 Feb 24
Results of Operations and Financial Condition
1:06pm
8-K
cac7ycd 5z
1 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
edkdp
8 Jan 24
Regulation FD Disclosure
8:00am
8-K
p1k7oj
5 Jan 24
Regulation FD Disclosure
8:00am
8-K
69g0iny4pdfu 9y7dfo
19 Dec 23
Regulation FD Disclosure
5:00pm
8-K
d5v1w2
12 Dec 23
Entry into a Material Definitive Agreement
5:17pm
8-K
10r77
5 Dec 23
Departure of Directors or Certain Officers
5:00pm
8-K
rjwi3r hefq18
14 Nov 23
Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results
4:51pm
8-K
2p0 vs0ho6
30 Oct 23
Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer
6:30am
8-K
1jd0abc4uq d8
27 Oct 23
Departure of Directors or Certain Officers
5:00pm
8-K/A
lrefum
24 Oct 23
Departure of Directors or Certain Officers
5:14pm